Open AccessEFFICACY OF DRUG THERAPY OF CHRONIC HEART FAILURE IN YOUNG CHILDREN WITH DILATED CARDIOMYOPATHY
Author(s) -
О. П. Жарова,
Е. Н. Басаргина,
А. П. Фисенко,
Л. А. Гандаева,
Yu. V. Derevnina
Publication year - 2019
Publication title -
rossijskij pediatričeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2413-2918
pISSN - 1560-9561
DOI - 10.18821/1560-9561-2019-22-4-219-225
Subject(s) - medicine , dilated cardiomyopathy , heart failure , drug , pharmacotherapy , medical prescription , cardiology , cardiomyopathy , adverse effect , intensive care medicine , pharmacology
Dilated cardiomyopathy in children is a very serious disorder with a poor outcome. However, clinical practice has shown that young children have a higher capability to recover cardiac function, which requires an active approach to the prescription of drug therapy. Currently, the combined therapy of chronic heart failure, including ACE inhibitors, beta-blockers, aldosterone antagonists, diuretics, demonstrates high efficiency in reducing the severity of heart failure symptoms, and in improving or stabilizing laboratory and instrumental parameters. Early and adequate administration of drug therapy can improve the prognosis of the disease and prevent an adverse outcome.